Stages of Thyroid Eye Disease: What They Are and How to Treat Them

Thyroid eye disease, or TED, is one of those conditions that sounds oddly specific until it barges into real life and starts changing how your eyes feel, look, and work. It can cause dryness, swelling, pressure, double vision, and that classic “my eyes seem bigger than usual” moment nobody asked for. Most often, it shows up in people with Graves’ disease, but TED has a mind of its own and does not always follow a tidy thyroid script.

If you have been searching for the “stages” of thyroid eye disease, here is the most useful way to think about it: doctors usually describe TED using two disease phases and a separate severity scale. In plain English, that means the disease has an active stage and an inactive stage, while also being labeled as mild, moderate-to-severe, or sight-threatening. Yes, it is a little like having both a season and a movie rating at the same time.

Understanding that difference matters because treatment is not just about what symptoms you have. It is also about when those symptoms are happening and how dangerous they are. A gritty, watery eye in early TED is handled very differently from vision loss caused by pressure on the optic nerve.

What is thyroid eye disease, exactly?

TED is an autoimmune condition that affects the tissues around the eyes, including fat, connective tissue, and eye muscles. Inflammation causes these tissues to swell, which can push the eyes forward, pull the eyelids back, and make eye movement less smooth. That is why one person may mainly have puffiness and dryness, while another gets double vision or trouble fully closing the eyelids.

Although TED is strongly linked to Graves’ disease, it is not simply a cosmetic side effect of an overactive thyroid. It is its own eye disorder. That means getting thyroid hormone levels under control is important, but it may not be enough on its own. Many people need dedicated eye treatment too.

The two main stages of thyroid eye disease

Stage 1: The active, inflammatory stage

This is the phase when TED is “turned on.” The immune system is actively stirring up inflammation in the tissues behind and around the eyes. Symptoms can change over weeks or months, and they often fluctuate just enough to keep people confused. One day your eyes may feel mostly dry and annoying. The next day they may feel tight, achy, swollen, and more sensitive to light.

Common signs of the active stage include:

• Red, gritty, irritated eyes
• Puffy eyelids and swelling around the eyes
• Bulging eyes, also called proptosis
• Eyelid retraction, where the upper lids sit higher than usual
• Eye pressure or pain, especially when moving the eyes
• Double vision
• Light sensitivity
• Tearing, dryness, or both at the same inconvenient time

This phase often lasts from several months up to about one to two years, though some people experience a longer course. During this time, the goal is not just to make you more comfortable. It is to calm inflammation, protect the surface of the eye, preserve vision, and reduce the risk of long-term damage.

Stage 2: The inactive, stable stage

Eventually, the inflammation cools down. That does not always mean the eyes return to their old selves. It means the disease has become more stable. By this point, swelling may improve, but the changes left behind can remain. Scarring and tissue remodeling may leave a person with persistent bulging, lid retraction, or double vision even after the inflammatory fireworks are over.

In the inactive stage, symptoms are usually less “hot” and less variable. The appearance and function of the eyes are more stable from visit to visit. This is important because many surgical treatments work best after the disease has settled down. Operating too early can be like tailoring a suit while the wearer is still growing. The measurements may change.

Severity matters just as much as stage

Here is where many articles get fuzzy. TED is not staged only by time. Doctors also classify it by severity. A person can have mild active TED, moderate-to-severe active TED, or sight-threatening TED. Someone else may have moderate-to-severe inactive TED. Same disease, very different treatment plan.

Mild TED

Mild disease usually means symptoms are bothersome but not truly dangerous. Think dryness, tearing, mild swelling, slight bulging, and intermittent double vision that does not wreck daily function. Many people fall into this group.

Moderate-to-severe TED

This category means the disease is doing more than being irritating. It may significantly affect daily activities, appearance, comfort, or eye movement. Persistent double vision, more pronounced bulging, and significant soft tissue inflammation often land people here.

Sight-threatening TED

This is the emergency category. It usually means one of two things is happening: the optic nerve is being compressed, or the surface of the eye is in danger because the lids do not protect it well enough. This is not the moment for home remedies and optimism. It is the moment for urgent specialty care.

How doctors figure out your stage

Eye specialists do not just look at a photo and say, “Yep, that seems thyroid-ish.” They use a full exam to assess activity and severity. This often includes visual acuity, color vision, eye pressure, lid position, eye movement, corneal health, and measurements of how far the eyes protrude. Blood tests help evaluate thyroid function, and imaging such as CT or MRI may be used when the diagnosis is unclear, the disease looks asymmetric, or the team is concerned about optic nerve compression.

Many clinicians also use a tool called the Clinical Activity Score, or CAS, to estimate how inflamed the disease is at the moment. It is one piece of the puzzle, not the whole puzzle, but it helps guide treatment decisions.

How each stage is treated

Treatment for mild active TED

For mild active disease, the first job is symptom control and risk reduction. This can include:

• Artificial tears during the day
• Lubricating gel or ointment at night
• Sunglasses for light sensitivity and wind protection
• Sleeping with the head elevated to reduce morning puffiness
• Taping the eyelids shut at night if they do not close completely
• Prism glasses for selected cases of double vision
• Strict smoking cessation

Smoking deserves its own spotlight because it is one of the clearest modifiable risk factors for TED progression. In other words, quitting smoking is not “nice to have.” It is a real part of treatment.

Some specialists also consider selenium supplementation in selected patients with mild disease, especially early on. It is not a magic pill, and it is not universally useful in every setting, but it remains part of many mild-disease discussions.

Treatment for moderate-to-severe active TED

Once the disease becomes more inflammatory or more disruptive, treatment usually needs more muscle. This is where specialist care becomes especially important.

Common options include:

• Intravenous corticosteroids: Often used to reduce orbital inflammation relatively quickly. They can help swelling and pain, but they come with side effects and are not ideal for everyone.
• Teprotumumab: A targeted biologic therapy used for thyroid eye disease. It has changed the treatment conversation because it can improve bulging and other signs in selected patients. It is given by IV infusion in a course of eight treatments.
• Orbital radiation: Sometimes used in selected cases, especially when inflammation and eye muscle involvement are prominent.
• Other immunomodulatory therapies: In complex cases, specialists may consider additional medications depending on the disease pattern and how the patient responds.

Teprotumumab gets a lot of attention, and fairly so, but it is not a casual wellness drip. It has real potential benefits and real precautions. Hearing problems, high blood sugar, infusion reactions, gastrointestinal issues, and other adverse effects all need to be weighed carefully. The best candidates are chosen by a team that understands both the eye disease and the rest of the patient’s health picture.

Treatment for sight-threatening TED

If TED threatens vision, treatment becomes urgent. High-dose intravenous steroids are often used first, and some patients need orbital decompression surgery quickly if the optic nerve remains under pressure or the eye surface is breaking down. This is the stage where speed matters. Waiting for the next routine appointment is a bad strategy.

Warning signs that need urgent evaluation include:

• Sudden drop in vision
• New blurred vision that is getting worse
• Loss of color brightness
• Severe exposure of the eye because the lids do not close
• Rapid worsening of pain, pressure, or swelling

Treatment for inactive TED

Once TED becomes stable and inactive, the goal often shifts from calming inflammation to restoring function and appearance. This is when rehabilitative surgery enters the chat.

Surgery is often done in a sequence:

1. Orbital decompression to create more room in the eye socket and reduce bulging
2. Strabismus surgery to improve eye alignment and double vision
3. Eyelid surgery to improve lid position and eye closure

That order is not random. Each step can affect the next one. Fixing eyelids before eye alignment or orbital position is stable is a bit like hanging curtains before the walls are finished.

What about thyroid treatment itself?

Keeping thyroid hormone levels well controlled is essential throughout every stage of TED. Poorly controlled thyroid function can make eye disease harder to manage. Endocrinology and ophthalmology often need to work together, especially in moderate-to-severe cases.

There is also nuance around radioactive iodine treatment for Graves’ disease. In some situations, it may worsen or reactivate eye problems, especially in active disease or in people with risk factors such as smoking. That does not mean it is never used, but it does mean treatment decisions should be individualized rather than made by dartboard.

Can thyroid eye disease go away?

The active inflammation often settles, yes. But TED does not always leave quietly or return everything to factory settings. Some people recover with minimal long-term changes. Others are left with persistent bulging, lid changes, or double vision that require surgery or long-term management. Early recognition, smoking cessation, coordinated care, and treatment matched to the correct stage give patients the best chance of a better outcome.

What patients often experience at each stage

One of the hardest parts of TED is that it affects both function and identity. Eyes are not exactly low-profile body parts. When they change, people notice. Friends notice. Cameras notice. Video calls definitely notice.

In the active stage, many people describe a strange mismatch between what they feel and what others assume. Someone may say, “My eyes are just dry,” while privately dealing with pain when looking sideways, tearing in the grocery store, headaches by afternoon, and a sudden inability to wear contact lenses comfortably. Mornings can be especially rough because swelling tends to be worse after lying flat overnight.

As inflammation builds, daily life may become more complicated in quiet, stubborn ways. Reading for long periods can be tiring. Driving at night may feel stressful if double vision starts to appear. Wind, bright sunlight, air-conditioning vents, and computer screens can all seem personally offended by your existence. Some people become reluctant to socialize because they feel they look startled, angry, or unlike themselves even when they feel fine.

During moderate-to-severe active TED, the experience can become less about annoyance and more about adaptation. People may tilt their heads to reduce double vision, stop wearing eye makeup because lid swelling changes the whole landscape, or plan the day around when their eyes are least irritated. Work meetings become harder when eye contact feels uncomfortable or when the screen blurs after an hour. Even good news, like finally getting a diagnosis, can come with a side helping of “Wait, this can affect my vision too?”

Then comes the stable stage, which is emotionally complicated in its own way. The inflammation may have calmed, but the mirror may still reflect bulging, lid retraction, or misaligned eyes. Patients often say this stage is oddly frustrating because they are told the disease is “inactive,” yet they are still living with very active consequences. On the bright side, this is also the stage when reconstructive planning becomes more realistic and more effective.

For people who go on to surgery, the journey is usually stepwise rather than one dramatic movie montage. A person might first undergo decompression to reduce pressure and prominence, then later have eye muscle surgery to improve double vision, and only after that move on to eyelid correction. Progress is real, but it often happens in chapters, not fireworks.

The common thread through all these experiences is that TED is not vanity medicine. It affects comfort, concentration, confidence, driving, reading, sleep, work, and sometimes vision itself. Patients tend to do best when their symptoms are taken seriously early, when they stop smoking if they smoke, and when care is coordinated between thyroid and eye specialists instead of handled as two unrelated plotlines.

Final takeaway

The “stages” of thyroid eye disease are best understood as an active inflammatory phase followed by an inactive stable phase, with severity ranging from mild to moderate-to-severe to sight-threatening. That framework matters because treatment depends on both timing and severity. Mild active disease may be managed with lubrication, lifestyle measures, and close follow-up. Moderate-to-severe active disease may need steroids, teprotumumab, radiation, or other specialist-directed therapy. Sight-threatening disease is urgent. Stable inactive disease is often the time for surgical rehabilitation.

Most of all, TED is treatable, but it is not something to shrug off as “just puffy eyes.” When vision, eye closure, pain, or double vision enter the picture, specialist evaluation is worth it sooner rather than later.